Podium to Practice: EHA 2025 – Leukemia: PETHEMA REGISTRY
OR
Explore more from your favourite experts – click their name to access their entire library of content.
Chair
Speakers
Studies / Trials Discussed
S146 – REFINEMENT OF THE ELN2022 PROGNOSTIC SUBGROUPS IN A REAL-LIFE COHORT OF 1747 INTENSIVELY TREATED ADULT AML PATIENTS OF THE PETHEMA REGISTRY
Studies/trials discussed:
S146 – REFINEMENT OF THE ELN2022 PROGNOSTIC SUBGROUPS IN A REAL-LIFE COHORT OF 1747 INTENSIVELY TREATED ADULT AML PATIENTS OF THE PETHEMA REGISTRY
199 Bay Street #4000
Toronto, ON M5L 1A9
©2025 OncologyEducation a Think Research company. All rights reserved. Privacy Policy. Privacy Notice. Accessibility Statement.
Pre-Video Survey
By continuing to watch the video, you consent to receiving a post-view survey by email.